Active-ingredient Dossier
Brimonidine Tartrate
Active-ingredient Dossier for Brimonidine Tartrate (alpha-2 adrenergic agonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: COMBIGAN
- Brand: SIMBRINZA
- Brand: ALPHAGAN
- Brand: MIRVASO
- Brand: ENIDIN
- Brand: LUMIFY
- Therapeutic area: Ophthalmology
- Therapeutic area: Dermatology
What is
Brimonidine Tartrate Brimonidine Tartrate is an alpha-2 adrenergic agonist.
Australian brands containing
Brimonidine Tartrate — ALPHAGAN — MIRVASO — COMBIGAN — ENIDIN — SIMBRINZA — LUMIFY
Therapeutic areas
Brimonidine Tartrate is registered in ophthalmology (5 brands) and dermatology (1 brand).
Sponsor landscape
The ingredient is marketed by AbbVie, Bausch & Lomb, Galderma, and Novartis Pharmaceuticals.
PBS and regulatory activity
One brand containing brimonidine tartrate has a PBS-listed item, with the latest PBS schedule date of 1 May 2026. The latest AusPAR was dated 1 August 2014.